The U.S. Securities and Exchange Commission (SEC) is signaling support for streamlined “minimum effective dose” disclosure rules and tightly scoped equity‑tokenization pilots via an innovation exemption, according to new remarks from Chair Paul S. Atkins. The U.S. Securities and Exchange…News, Cryptocurrency, DeFi, ExchangeRead More

You might also be interested in reading Wall Street stocks slide as sell-off in tech shares picks up pace.